Lippo Karawaci Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Lippo Karawaci Tbk. trades at Rp63 (market cap 4.25T, 148.64M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 2.7× Lippo Karawaci Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (148.64M versus 1.77M). Which is the better fit depends on your goals.
| LPKR | TSPC | |
|---|---|---|
Market Cap | 4.25T | 11.36T |
Volume | 148.64M | 1.77M |
Lot | 1.49M | 17.71K |
Turnover | 9.21B | 4.61B |
Average Price | 61.95 | 2,603.9 |
Value | 9.21B | 4.61B |
Indicative Equilibrium Price | 63 | 2,590 |
Indicative Equilibrium Volume | 18.08K | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →